Skip to main content

In a study involving 44 participants aged 20-62, researchers observed after four weeks of daily consumption of the probiotic DE111 at 1 billion CFU a significant decrease in the basal levels of several immune cell populations, including CD3+ T cells, cytotoxic T cells, and NKT cells. Moreover, the probiotic group showed an increased capacity for immune response in cells stimulated by an induced inflammation. The results suggests that DE111 may modulate the immune system through action on both innate (rapid response) and adaptive (slow response) immune cell types.

VIEW PUBLISHED STUDY

More Resources

Kombucha: Tap into Consumer Desires Through Real Probiotic Benefits
It’s a great time to be in the booch business. Adding DE111 to your kombucha will ease your mind about…
More
White Paper: Crack Open the Functional Beverage Market
Innovation for drinks used to mean new packaging or clever marketing. Now innovation means redesigning the drinks themselves. Beverages are…
More
Probiotic Strain DE111 Found to Reduce Inflammatory Compounds in Athletes in Clinical Study
A new study has found that athletes who consumed a probiotic daily may benefit by boosting immune function and recovery…
More